This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Henry Schein, Quintessence Reach Strategic Partnership

NEW YORK, Nov. 26, 2012 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, and Quintessence Publishing Co., Inc., the world's leading independent publisher of scientific and clinical information about oral health, today announced a strategic partnership that will expand the availability of oral health education to the profession.

At the heart of the partnership is a joint commitment on the part of Henry Schein and Quintessence to provide the best and latest clinical information on treating oral disease so practitioners can provide the most advanced care possible for their patients.

Under the agreement, Henry Schein will use its industry-leading distribution network to market in North America the book titles, professional journals, and multimedia products published by Quintessence, whose work has earned many prestigious international prizes and awards during the company's 62-year history.

The companies also announced a partnership to present a co-branded symposium to explore the connection of oral health and systemic health. This symposium will occur in February 2014 and will be led by Dr. Michael Glick, DMD, Dean of the School of Dental Medicine at the University at Buffalo and Editor of The Journal of the American Dental Association.

"We are delighted to partner with Quintessence, which is known throughout the profession for publishing the highest-quality educational materials devoted to oral health," said Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein. "Henry Schein is committed to helping improve the business of our health care customers so they can improve the lives of their patients. By making the Quintessence portfolio available to our customers, we are helping to provide oral health care professionals with the very latest in clinical best practices. By partnering in the symposium, together we are doing our part to raise awareness of the connection between oral health and overall health for the benefit of our customers' patients."

Quintessence, based in Berlin, Germany, with U.S. operations outside of Chicago, takes pride in fostering scientific and clinical discourse in the oral health community.

"This strategic partnership with Henry Schein gives us the opportunity to expand that community, one dentist at a time," said William Hartman, Executive Vice President of Quintessence. "Each reader provides added depth and a new perspective to our community. Our goal is to work with acknowledged experts to publish the best and most useful books within every specialty, and we know that Henry Schein is dedicated to promoting this same professional excellence."

The one-year publishing agreement between Henry Schein and Quintessence will renew automatically for successive one-year terms. The Henry Schein sales network will market the Quintessence portfolio, which includes 50 professional journals and more than 1,000 book titles. Quintessence will manage the delivery of materials directly to customers.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,979.13 +59.54 0.35%
S&P 500 1,986.51 +4.91 0.25%
NASDAQ 4,526.4820 -1.0320 -0.02%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs